Literature DB >> 29456705

Discrimination of malignant transformation from benign endometriosis using a near-infrared approach.

Naoki Kawahara1, Yuki Yamada1, Fuminori Ito1, Wataru Hojo2, Takuya Iwabuchi2, Hiroshi Kobayashi1.   

Abstract

The aim of the present single-center retrospective study was to investigate the discrimination of malignant transformation from ovarian endometrioma (OE) using a near-infrared approach ex vivo. Cystic fluid samples were collected from patients with OE (n=34) and endometriosis-associated ovarian cancer (EAOC) (n=12). The light reflected from each sample of cystic fluid [change in luminance, Δl (cd/m2) = background luminance-cystic fluid luminance at 800 nm] was spectrally measured by a near-infrared CCD camera with band-path filter (800 nm). The Δl in EAOC was significantly lower compared with that in OE. On regression analysis, a positive correlation was observed between the Δl and Hb level in the cystic fluid, and this association was exponential. The diagnostic sensitivity and specificity of Δl was 83.3 and 94.1% at the cutoff value of 21.5 cd/m2, with an area under the ROC curve of 0.897. The present ex vivo study potentially provides a powerful near-infrared approach for quantitative discrimination between EAOC and benign OE, with high sensitivity and specificity, which may have clinical applications.

Entities:  

Keywords:  endometriosis; malignant transformation; near infrared; ovarian cancer

Year:  2018        PMID: 29456705      PMCID: PMC5795507          DOI: 10.3892/etm.2018.5779

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  12 in total

1.  Data preprocessing and partial least squares regression analysis for reagentless determination of hemoglobin concentrations using conventional and total transmission spectroscopy.

Authors:  Y J Kim; S Kim; J W Kim; G Yoon
Journal:  J Biomed Opt       Date:  2001-04       Impact factor: 3.170

2.  Cyst fluid iron-related compounds as useful markers to distinguish malignant transformation from benign endometriotic cysts.

Authors:  Chiharu Yoshimoto; Takuya Iwabuchi; Hiroshi Shigetomi; Hiroshi Kobayashi
Journal:  Cancer Biomark       Date:  2015       Impact factor: 4.388

3.  Noninvasive detection of skeletal muscle underperfusion with near-infrared spectroscopy in patients with heart failure.

Authors:  J R Wilson; D M Mancini; K McCully; N Ferraro; V Lanoce; B Chance
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

4.  Current status of gynecologic cancer in Japan.

Authors:  Kimio Ushijima
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

5.  Cancer risk after a hospital discharge diagnosis of endometriosis.

Authors:  L A Brinton; G Gridley; I Persson; J Baron; A Bergqvist
Journal:  Am J Obstet Gynecol       Date:  1997-03       Impact factor: 8.661

Review 6.  Cerebral and tissue oximetry.

Authors:  Jochen Steppan; Charles W Hogue
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2014-09-28

7.  Cyst fluid hemoglobin species in endometriosis and its malignant transformation: The role of metallobiology.

Authors:  Takuya Iwabuchi; Chiharu Yoshimoto; Hiroshi Shigetomi; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

8.  Increased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort study.

Authors:  Hann-Chin Yu; Chun-Yi Lin; Wei-Chiao Chang; Biing-Jiun Shen; Wei-Pin Chang; Chi-Mu Chuang
Journal:  Int J Gynecol Cancer       Date:  2015-03       Impact factor: 3.437

9.  Dependence on NIRS source-detector spacing of cytochrome c oxidase response to hypoxia and hypercapnia in the adult brain.

Authors:  Christina Kolyva; Arnab Ghosh; Ilias Tachtsidis; David Highton; Martin Smith; Clare E Elwell
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 10.  Recent concepts of ovarian carcinogenesis: type I and type II.

Authors:  Masafumi Koshiyama; Noriomi Matsumura; Ikuo Konishi
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.